Cargando…

Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling

BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is listed as one of the most common causes of cancer-related death. Oncolytic therapy has become a promising treatment because of novel immunotherapies and gene editing technology, but biosafety concerns remain the biggest limitation for clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Liming, Niu, Yongdong, Sun, Jiating, Lin, Hong, Liang, Guoxi, Xiao, Min, Shi, Dongmei, Wang, Jia, Zhu, Huachen, Guan, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039698/ https://www.ncbi.nlm.nih.gov/pubmed/35528990 http://dx.doi.org/10.14218/JCTH.2021.00284

Ejemplares similares

Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma
por: Baiocchi, Leonardo, et al.
Publicado: (2022)

Newcastle Disease Virus/HK84: Next Potential Star for Targeted Immunotherapy of Hepatocellular Carcinoma?
por: Huang, Weiyi, et al.
Publicado: (2022)

Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model
por: Yurchenko, Kseniya S., et al.
Publicado: (2018)

Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells
por: Jiang, Ke, et al.
Publicado: (2018)

Newcastle Disease Virus (NDV) Oncolytic Activity in Human Glioma Tumors Is Dependent on CDKN2A-Type I IFN Gene Cluster Codeletion
por: García-Romero, Noemi, et al.
Publicado: (2020)

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro
por: Burke, Shannon, et al.
Publicado: (2020)

Oncolytic virus-derived type I interferon restricts CAR T cell therapy
por: Evgin, Laura, et al.
Publicado: (2020)

Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
por: Fournier, Philippe, et al.
Publicado: (2013)

Therapeutic potential of oncolytic Newcastle disease virus: a critical review
por: Tayeb, Shay, et al.
Publicado: (2015)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
por: Pathak, Upasana, et al.
Publicado: (2023)

A recombinant oncolytic Newcastle virus expressing MIP-3α promotes systemic antitumor immunity
por: Huang, Feng-Ying, et al.
Publicado: (2020)

Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model
por: Yurchenko, Kseniya S., et al.
Publicado: (2021)

Adaptation of the Newcastle Disease Virus to Cell Cultures for Enhancing Its Oncolytic Properties
por: Yurchenko, K. S., et al.
Publicado: (2019)

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy
por: Huang, Fang, et al.
Publicado: (2022)

Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy
por: Schirrmacher, Volker, et al.
Publicado: (2022)

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
por: Liu, Tianyan, et al.
Publicado: (2020)

Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma
por: Buijs, Pascal, et al.
Publicado: (2015)

Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
por: Schirrmacher, Volker, et al.
Publicado: (2019)

Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis
por: Keshavarz, Mohsen, et al.
Publicado: (2020)

Molecular Mechanisms of Anti-Neoplastic and Immune Stimulatory Properties of Oncolytic Newcastle Disease Virus
por: Schirrmacher, Volker
Publicado: (2022)

Investigation of oncolytic effect of recombinant Newcastle disease virus in primary and metastatic oral melanoma
por: Numpadit, Supaporn, et al.
Publicado: (2023)

Papaverine Enhances the Oncolytic Effects of Newcastle Disease Virus on Breast Cancer In Vitro and In Vivo
por: Akram, Sura, et al.
Publicado: (2023)

Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
por: Wang, Cong-Jun, et al.
Publicado: (2012)

Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response
por: Achard, Carole, et al.
Publicado: (2015)

Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity
por: Bourgeois-Daigneault, Marie-Claude, et al.
Publicado: (2016)

Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer
por: Chai, Zheng, et al.
Publicado: (2014)

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity
por: Harper, James, et al.
Publicado: (2021)

Interferon signaling predicts response to oncolytic virotherapy
por: Kurokawa, Cheyne, et al.
Publicado: (2019)

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
por: Fiorino, Erika, et al.
Publicado: (2022)

Exploring the Prognosis of Breast Cancer with Synchronous Distant Nonregional Lymph Node Metastasis and Establishing a Predictive Model: A Population-Based Study
por: Lin, Hong, et al.
Publicado: (2022)

Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
por: Meng, Gang, et al.
Publicado: (2014)

Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014)

STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells
por: Shao, Xiaoyan, et al.
Publicado: (2019)

Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma
por: Vijayakumar, Gayathri, et al.
Publicado: (2019)

Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds
por: Ayala, Andrea J., et al.
Publicado: (2016)

Structural Basis for the Inhibition of the Autophosphorylation Activity of HK853 by Luteolin
por: Zhou, Yuan, et al.
Publicado: (2019)

Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration
por: Mikkelsen, Randi Bonke, et al.
Publicado: (2022)

Effects of Chicken Interferon Gamma on Newcastle Disease Virus Vaccine Immunogenicity
por: Cardenas-Garcia, Stivalis, et al.
Publicado: (2016)

Interferons Regulate the Phenotype of Wild-type and Mutant Herpes Simplex Viruses In Vivo
por: Leib, David A., et al.
Publicado: (1999)

Type I Interferons Keep Activated T Cells Alive
por: Marrack, Philippa, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_67po5ir4fhdo1ep1dukkahpstv